ES545347A0 - Un procedimiento para preparar derivados de pirimidina - Google Patents
Un procedimiento para preparar derivados de pirimidinaInfo
- Publication number
- ES545347A0 ES545347A0 ES545347A ES545347A ES545347A0 ES 545347 A0 ES545347 A0 ES 545347A0 ES 545347 A ES545347 A ES 545347A ES 545347 A ES545347 A ES 545347A ES 545347 A0 ES545347 A0 ES 545347A0
- Authority
- ES
- Spain
- Prior art keywords
- preparing
- procedure
- pirimidine derivatives
- pirimidine
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848418380A GB8418380D0 (en) | 1984-07-19 | 1984-07-19 | Pyrimidine derivatives |
GB848424711A GB8424711D0 (en) | 1984-10-01 | 1984-10-01 | Pyrimidine derivatives |
GB858509623A GB8509623D0 (en) | 1985-04-15 | 1985-04-15 | Pyrimidine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8700661A1 ES8700661A1 (es) | 1986-10-16 |
ES545347A0 true ES545347A0 (es) | 1986-10-16 |
Family
ID=27262418
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES545347A Expired ES8700661A1 (es) | 1984-07-19 | 1985-07-18 | Un procedimiento para preparar derivados de pirimidina |
Country Status (10)
Country | Link |
---|---|
US (1) | US4698340A (es) |
EP (1) | EP0169712B1 (es) |
JP (1) | JPH0649688B2 (es) |
AU (1) | AU4520285A (es) |
DE (1) | DE3580875D1 (es) |
DK (1) | DK327985A (es) |
ES (1) | ES8700661A1 (es) |
FI (1) | FI852796L (es) |
GR (1) | GR851735B (es) |
NO (1) | NO852869L (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3508533A1 (de) * | 1985-03-09 | 1986-09-11 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von benzylidenverbindungen |
DE3675197D1 (de) * | 1985-12-03 | 1990-11-29 | Sumitomo Chemical Co | Pyridinylpyrimidin-derivate, verfahren zu deren herstellung und diese als wirksamen stoff enthaltende pflanzenkrankheiten-schutzmittel. |
GB8530602D0 (en) * | 1985-12-12 | 1986-01-22 | Fujisawa Pharmaceutical Co | Heterocyclic compounds |
CA1288433C (en) * | 1986-12-03 | 1991-09-03 | Tsuguhiro Katoh | Pyridinylpyrimidine derivatives, method for production thereof and a fungicide containing them as the active ingredient |
IL91418A (en) * | 1988-09-01 | 1997-11-20 | Rhone Poulenc Agrochimie | (hetero) cyclic amide derivatives, process for their preparation and fungicidal compositions containing them |
FR2649699A1 (fr) * | 1989-07-13 | 1991-01-18 | Rhone Poulenc Agrochimie | 4-phenyl pyrimidine fongicides |
MX9701765A (es) * | 1994-09-09 | 1997-06-28 | Nippon Shinyaku Co Ltd | Derivado heterociclico y medicina. |
US5594141A (en) * | 1994-11-23 | 1997-01-14 | Neurogen Corporation | Certain aminomethyl biphenyl, aminomethyl phenyl pyridine and aminomethyl phenyl pyrimidine derivatives; novel dopamine receptor subtype selective ligands |
KR20010041015A (ko) | 1998-02-17 | 2001-05-15 | 윌리엄 제이. 리플린 | 항바이러스성 피리미딘 유도체 |
DE19817264A1 (de) * | 1998-04-18 | 1999-10-21 | Bayer Ag | Neue Dihydropyrimidine |
DE19817265A1 (de) | 1998-04-18 | 1999-10-21 | Bayer Ag | Verwendung von Dihydropyrimidinen als Arzneimittel und neue Stoffe |
TW550258B (en) | 1999-05-31 | 2003-09-01 | Hoffmann La Roche | 4-phenyl-pyrimidine derivatives |
US6410726B1 (en) | 2000-01-12 | 2002-06-25 | Tularik Inc. | Arylsulfonic acid salts of pyrimidine-based antiviral |
AU2001284504A1 (en) * | 2000-09-14 | 2002-03-26 | Ajinomoto Co., Inc. | Novel pyrimidine derivative and novel pyridine derivative |
ES2335279T3 (es) * | 2002-12-16 | 2010-03-24 | Astrazeneca Uk Limited | Procedimiento para la preparacion de compuestos de pirimidina. |
HUP0400405A3 (en) * | 2004-02-10 | 2009-03-30 | Sanofi Synthelabo | Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates |
KR101595506B1 (ko) | 2008-02-01 | 2016-02-18 | 오키드 리서치 레버라토리즈 리미티드 | 신규한 헤테로사이클 |
GB0908394D0 (en) | 2009-05-15 | 2009-06-24 | Univ Leuven Kath | Novel viral replication inhibitors |
GB0913636D0 (en) | 2009-08-05 | 2009-09-16 | Univ Leuven Kath | Novel viral replication inhibitors |
KR20140003438A (ko) | 2010-11-15 | 2014-01-09 | 카톨리에케 유니버시테이트 루벤 | 항바이러스성 축합 헤테로사이클릭 화합물 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3944581A (en) * | 1974-11-01 | 1976-03-16 | Morton-Norwich Products, Inc. | 5-Substituted-2,4-diphenylpyrimidines |
US3969355A (en) * | 1974-11-01 | 1976-07-13 | Morton-Norwich Products, Inc. | 5-Aminoethyl-2,4-diphenylpyrimidine dihydrobromide |
US4382140A (en) * | 1982-01-26 | 1983-05-03 | Norwich Eaton Pharmaceuticals, Inc. | 2,4-Diphenyl-5-pyrimidinecarbonitrile |
DE3234684A1 (de) * | 1982-09-18 | 1984-03-22 | Bayer Ag, 5090 Leverkusen | Neue dihydropyrimidine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
US4727073A (en) * | 1984-10-01 | 1988-02-23 | Fujisawa Pharmaceutical Co., Ltd. | Pyrimidine derivatives and composition of the same |
-
1985
- 1985-07-11 US US06/753,912 patent/US4698340A/en not_active Expired - Fee Related
- 1985-07-12 GR GR851735A patent/GR851735B/el unknown
- 1985-07-17 FI FI852796A patent/FI852796L/fi not_active Application Discontinuation
- 1985-07-18 NO NO852869A patent/NO852869L/no unknown
- 1985-07-18 ES ES545347A patent/ES8700661A1/es not_active Expired
- 1985-07-18 DK DK327985A patent/DK327985A/da not_active Application Discontinuation
- 1985-07-18 EP EP85305143A patent/EP0169712B1/en not_active Expired - Lifetime
- 1985-07-18 DE DE8585305143T patent/DE3580875D1/de not_active Expired - Fee Related
- 1985-07-19 JP JP60160784A patent/JPH0649688B2/ja not_active Expired - Lifetime
- 1985-07-19 AU AU45202/85A patent/AU4520285A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES8700661A1 (es) | 1986-10-16 |
DK327985A (da) | 1986-01-20 |
FI852796L (fi) | 1986-01-20 |
EP0169712B1 (en) | 1990-12-12 |
US4698340A (en) | 1987-10-06 |
GR851735B (es) | 1985-11-26 |
EP0169712A2 (en) | 1986-01-29 |
DK327985D0 (da) | 1985-07-18 |
EP0169712A3 (en) | 1986-12-03 |
JPH0649688B2 (ja) | 1994-06-29 |
JPS6140272A (ja) | 1986-02-26 |
AU4520285A (en) | 1986-01-23 |
NO852869L (no) | 1986-01-20 |
DE3580875D1 (de) | 1991-01-24 |
FI852796A0 (fi) | 1985-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES542051A0 (es) | Un procedimiento para preparar derivados de benzoilurea | |
ES554380A0 (es) | Un procedimiento para preparar derivados de 8-fenilxantina | |
ES548135A0 (es) | Un procedimiento para preparar dioxafosforinanos | |
ES554567A0 (es) | Un procedimiento para preparar derivados de 8-amino-purina | |
ES543047A0 (es) | Un procedimiento para preparar un derivado de pirimidina | |
ES543732A0 (es) | Un procedimiento para preparar derivados de aminoalquilfenaxi. | |
ES545771A0 (es) | Un procedimiento para preparar derivados de quiniona. | |
ES543192A0 (es) | Un procedimiento para preparar aril-hidroxamatos | |
ES553610A0 (es) | Un procedimiento para preparar derivados de alanil-protina. | |
ES545347A0 (es) | Un procedimiento para preparar derivados de pirimidina | |
ES548409A0 (es) | Un procedimiento para preparar derivados de bencimidazol | |
ES543929A0 (es) | Un procedimiento para preparar un p-isononanoiloxibenceno- sulfonato | |
ES551064A0 (es) | Un metodo para preparar derivados de cefem | |
ES546157A0 (es) | Un procedimiento para preparar quinolonas | |
ES547419A0 (es) | Un procedimiento para preparar derivados de pirimidina | |
ES542149A0 (es) | Un procedimiento para preparar hidroxi-4-2h-1-benzotiopiran-2-onas | |
ES552617A0 (es) | Un procedimiento para preparar derivados de bencimidazol | |
ES554238A0 (es) | Un precedimiento para preparar derivados de ciclopentil-eter | |
ES544864A0 (es) | Un procedimiento para preparar 4-acetoxi-3-hidroxietilazeti-zin-2-ona | |
ES552912A0 (es) | Un procedimiento para preparar derivados de 3-carbonil-1-aminoalquil-1h-indol | |
ES545111A0 (es) | Un procedimiento para preparar un derivado de fluoralilamina | |
ES555010A0 (es) | Un procedimiento para preparar derivados de 3-oxobutanamido-acetato. | |
ES550467A0 (es) | Un metodo para preparar derivados de 9-bencilpurina | |
ES546690A0 (es) | Un procedimiento para preparar derivados de azirino-pirrolo-indoldiona | |
ES547458A0 (es) | Un procedimiento para preparar derivados de piridiloxi |